Our own work using a pre-2022 cohort of smallpox-vaccinated individuals shows that while no post-vaccination timepoint is significantly different from the control group, there is a clear trend toward higher neutralizing titers after the second dose of vaccination.
← all excerpts
The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response.
1
—
—